ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-020-04584-9
PubMed Identifier: 32736596
Publication URI: http://europepmc.org/abstract/MED/32736596
Type: Journal Article/Review
Volume: 21
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215